24 research outputs found

    BMC Anesthesiol

    Get PDF
    No previous study investigated the dexmedetomidine-based opioid-free anesthesia (OFA) protocol in cardiac surgery. The main objective of this study was to evaluate the feasibility and the postoperative opioid-sparing effect of dexmedetomidine-based OFA in adult cardiac surgery patients. We conducted a single-centre and retrospective study including 80 patients above 18 years old who underwent on-pump cardiac surgery between November 2018 and February 2020. Patients were divided into two groups: OFA (lidocaine, ketamine, dexmedetomidine, MgSO4) or opioid-based anaesthesia (remifentanil and anti-hyperalgesic medications such as ketamine and/or MgSO4 and/or lidocaine at the discretion of the anesthesiologist). The primary endpoint was the total amount of opioid consumed in its equivalent of intravenous morphine during the first 48 postoperative hours. Secondary outcomes included perioperative hemodynamics, post-operative maximal pain at rest and during coughing and adverse outcomes. Data are expressed as median [interquartile range]. Patients in the OFA-group had a higher EuroSCORE II, with more diabetes, more dyslipidemia and more non-elective surgery but fewer smoking history. In the OFA group, the median loading dose of dexmedetomidine was 0.6 [0.4-0.6] μg.kg while the median maintenance dose was 0.11 μg.kg.h [0.05-0.20]. In 10 (25%) patients, dexmedetomidine was discontinued for a drop of mean arterial pressure below 55 mmHg. The median total amount of opioid consumed in its equivalent of intravenous morphine during the first 48 postoperative hours was lower in the OFA group (15.0 mg [8.5-23.5] versus 30.0 mg [17.3-44.3], p < 0.001). While no differences were seen with rest pain (2.0 [0.0-3.0] versus 0.5 [0.0-5.0], p = 0.60), the maximal pain score during coughing was lower in OFA group (3.5 [2.0-5.0] versus 5.5 [3.0-7.0], p = 0.04). In OFA group the incidence of atrial fibrillation (18% versus 40%, p = 0.03) and non-invasive ventilation use (25% versus 48%, p = 0.04) were lower. The incidence of bradycardia and the intraoperative use of norepinephrine were similar between both groups. Dexmedetomidine-based OFA in cardiac surgery patients is feasible and could be associated with a lower postoperative morphine consumption and better postoperative outcomes. Further randomized studies are required to confirm these promising results and determine the optimal associations, dosages, and infusion protocols during cardiac surgery

    Ultrasounds welding of nanocellulosic materials

    No full text
    International audienceThe interest for cellulose nanocrystals and nanofibrils is exponentially increased since last decade thanks to their industrialization. In addition to their low density, high aspect ratio, high stiffness and Young’s modulus and chemically reactive surface, this material is well known for its high specific surface. Thanks to these particular properties, cellulose nanomaterials can be used within a wide variety of applications. Coating is one of the promising applications for nanocellulose mainly for barrier applications in packaging. Indeed new bio-based but also high performance solutions are expected in food packaging. Unfortunately, up to now, high barrier solutions can be provided but they always require a layer of thermosealing polymer which is usually fossil based. These multilayer materials are also more complicate to handle when end of life is considered. One solution would be to propose cellulosic materials which could be welded easily. Except thermosealing, ultrasounds welding have been developed in plastic industry last years.This study is a proof of concept that nanocellulosic materials can be welded by ultrasounds. Several nanocellulosic materials were firstly designed and characterized, i.e. from classic cellulose nanocrystals and nanofibrils to functionalized CNC by esterification with lauric acid. Than model films were prepared and welded by ultrasounds. Process parameters were optimized and successful welding were obtained and mechanically characterized. These very positive results have been patented and open the doors for new solutions in welding of biobased materials

    Ultrasounds welding of nanocellulosic materials

    No full text
    International audienceThe interest for cellulose nanocrystals and nanofibrils is exponentially increased since last decade thanks to their industrialization. In addition to their low density, high aspect ratio, high stiffness and Young’s modulus and chemically reactive surface, this material is well known for its high specific surface. Thanks to these particular properties, cellulose nanomaterials can be used within a wide variety of applications. Coating is one of the promising applications for nanocellulose mainly for barrier applications in packaging. Indeed new bio-based but also high performance solutions are expected in food packaging. Unfortunately, up to now, high barrier solutions can be provided but they always require a layer of thermosealing polymer which is usually fossil based. These multilayer materials are also more complicate to handle when end of life is considered. One solution would be to propose cellulosic materials which could be welded easily. Except thermosealing, ultrasounds welding have been developed in plastic industry last years.This study is a proof of concept that nanocellulosic materials can be welded by ultrasounds. Several nanocellulosic materials were firstly designed and characterized, i.e. from classic cellulose nanocrystals and nanofibrils to functionalized CNC by esterification with lauric acid. Than model films were prepared and welded by ultrasounds. Process parameters were optimized and successful welding were obtained and mechanically characterized. These very positive results have been patented and open the doors for new solutions in welding of biobased materials

    A testing technique to investigate the tensile behavior of propellant representative material

    No full text
    Propellants are energetic materials abundantly used to generate the propulsion of rockets, projectiles, or other objects. A wide range of stress-state and strain-rate has to be considered in view of predicting the mechanical behaviour of this material over its different life cycles. Propellant materials are usually studied through the use of propellant representative materials (PRM) when studied in a university laboratory. In the present work an experimental device was developed to investigate the dynamic tensile response of a PRM material. This device is based on the use of a pendulum that is employed to dynamically load the PRM sample on one end. The sample is attached to an instrumented Hopkinson bar on the other end. The data processing of Hopkinson bar point measurements combined to DIC (digital-imagecorrelation) measurements allows the stress and strain levels in the sample to be characterised. Finally these experimental results can be used to enhance the constitutive modelling of PRM materials

    Feasibility and postoperative opioid sparing effect of an opioid-free anaesthesia in adult cardiac surgery: a retrospective study

    No full text
    International audienceBackground: No previous study investigated the dexmedetomidine-based opioid-free anesthesia (OFA) protocol in cardiac surgery. The main objective of this study was to evaluate the feasibility and the postoperative opioid-sparing effect of dexmedetomidine-based OFA in adult cardiac surgery patients.Methods: We conducted a single-centre and retrospective study including 80 patients above 18 years old who underwent on-pump cardiac surgery between November 2018 and February 2020. Patients were divided into two groups: OFA (lidocaine, ketamine, dexmedetomidine, MgSO4) or opioid-based anaesthesia (remifentanil and anti-hyperalgesic medications such as ketamine and/or MgSO4 and/or lidocaine at the discretion of the anesthesiologist). The primary endpoint was the total amount of opioid consumed in its equivalent of intravenous morphine during the first 48 postoperative hours. Secondary outcomes included perioperative hemodynamics, post-operative maximal pain at rest and during coughing and adverse outcomes. Data are expressed as median [interquartile range].Results: Patients in the OFA-group had a higher EuroSCORE II, with more diabetes, more dyslipidemia and more non-elective surgery but fewer smoking history. In the OFA group, the median loading dose of dexmedetomidine was 0.6 [0.4-0.6] μg.kg- 1 while the median maintenance dose was 0.11 μg.kg- 1.h- 1 [0.05-0.20]. In 10 (25%) patients, dexmedetomidine was discontinued for a drop of mean arterial pressure below 55 mmHg. The median total amount of opioid consumed in its equivalent of intravenous morphine during the first 48 postoperative hours was lower in the OFA group (15.0 mg [8.5-23.5] versus 30.0 mg [17.3-44.3], p < 0.001). While no differences were seen with rest pain (2.0 [0.0-3.0] versus 0.5 [0.0-5.0], p = 0.60), the maximal pain score during coughing was lower in OFA group (3.5 [2.0-5.0] versus 5.5 [3.0-7.0], p = 0.04). In OFA group the incidence of atrial fibrillation (18% versus 40%, p = 0.03) and non-invasive ventilation use (25% versus 48%, p = 0.04) were lower. The incidence of bradycardia and the intraoperative use of norepinephrine were similar between both groups.Conclusion: Dexmedetomidine-based OFA in cardiac surgery patients is feasible and could be associated with a lower postoperative morphine consumption and better postoperative outcomes. Further randomized studies are required to confirm these promising results and determine the optimal associations, dosages, and infusion protocols during cardiac surgery

    ASAIO J

    No full text
    Peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used in patients suffering from refractory cardiogenic shock (CS). Although considered life-saving, peripheral VA-ECMO may also be responsible for intracardiac hemodynamic changes, including left ventricular overload and dysfunction. Venoarterial extracorporeal membrane oxygenation may also increase myocardial wall stress and stroke work, possibly affecting the cellular cardioprotective and apoptosis signaling pathways, and thus the infarct size. To test this hypothesis, we investigated the effects of increasing the peripheral VA-ECMO blood flow (25-100% of the baseline cardiac output) on systemic and cardiac hemodynamics in a closed-chest CS model. Upon completion of the experiment, the hearts were removed for assessment of infarct size, histology, apoptosis measurements, and phosphorylation statuses of p38 and protein Kinase B (Akt), and extracellular signal-regulated kinase mitogen-activated protein kinases (ERK-MAPK). Peripheral VA-ECMO restored systemic perfusion but induced a significant and blood flow-dependent increase in left ventricular preload and afterload. Venoarterial extracorporeal membrane oxygenation did not affect infarct size but significantly decreased p38-MAPK phosphorylation and cardiac myocyte apoptosis in the border zone

    Fixing method

    No full text
    A method for fixing a first surface to a second surface. The method comprises depositing a first layer of nanocellulose on the first surface; bringing the first layer of nanocellulose into contact with the second surface or with a second layer of nanocellulose deposited on the second surface; and fixing the first layer of nanocellulose to the second surface, the second surface containing cellulose, or to the second layer of nanocellulose by a step of ultrasonic welding, which results in a first zone comprising the first layer of nanocellulose, where the first surface is fixed to the second surface, and a second zone around the first zone, where the first surface is not fixed to the second surface
    corecore